AccScience Publishing / MI / Online First / DOI: 10.36922/MI026330100
Cite this article
2
Download
51
Views
Related Info Links
More by Authors Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Clinical characteristics and antimicrobial exposure of patients positive for Candidozyma auris

Qingqing Xu1† ,  Jing Li2† ,  Huaming Guo1† ,  Minyu Liu3 ,  Lingbing Zeng4 ,  Xia Chen3 ,  Jiaxin Tu3 ,  Ling Zeng3 ,  Xiuhua Kang2,3*
Show Less
1 Department of Pulmonary and Critical Care, The First Affiliated Hospital, jiangxi medical college, Nanchang University, Nanchang, Jiangxi , China
2 Jiangxi Provincial Key Laboratory of Prevention and Treatment of Infectious Diseases, Jiangxi Medical Center for Critical Public Health Events, The First Affiliated Hospital, jiangxi medical college, Nanchang University, Nanchang, Jiangxi , China
3 Infection Control Division, The First Affiliated Hospital, jiangxi medical college, Nanchang University, Nanchang, Jiangxi , China
4 Department of Clinical Laboratory, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi , China
†These authors contributed equally to this work.
Received: 11 August 2026 | Revised: 14 October 2026 | Accepted: 21 October 2026 | Published online: 20 November 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Keywords
Candidozyma auris
Clinical characteristics
Intensive care unit
Microorganisms
Antibiotics
Funding
The study was supported by the Science and Technology Plan of Jiangxi Provincial Health Committee (grant no.: 202610322); Jiangxi Science and Technology Cooperation Project (grant no.: 20244BDF60008).
Conflict of interest
The authors declare that they have no competing interests.
References
  1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009;53:41-44. doi: 10.1111/j.1348-0421.2008.00083.x
  2. Lee WG, Shin JH, Uh Y, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49(9):3139-42. doi: 10.1128/jcm.00319-11
  3. Govender NP, Magobo RE, Mpembe R, et al. Candida auris in South Africa, 2012-2016. Emerg Infect Dis. 2018;24(11):2036-2040. doi: 10.3201/eid2411.180368
  4. Ruiz-Gaitán A, Martínez H, Moret AM, et al. Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients. Expert Rev Anti Infect Ther. 2019;17(4):295-305. doi: 10.1080/14787210.2019.1592675
  5. Azar MM, Turbett SE, Fishman JA, Pierce VM. Donor-derived transmission of Candida auris during lung transplantation. Clin Infect Dis. 2017;65(6):1040-1042. doi: 10.1093/cid/cix460
  6. Arenas SP, Persad PJ, Patel S, et al. Persistent colonization of Candida auris among inpatients rescreened as part of a weekly surveillance program. Infect Control Hosp Epidemiol. 2024;45(6):762-765. doi: 10.1017/ice.2023.251
  7. World Health Organization. WHO Fungal Priority Pathogens List to Guide Research, Development and Public Health Action. World Health Organization; 2022. Accessed November 19, 2026. https://www.who.int/publications/i/item/9789240060241
  8. Espiritu LM, Capule PRD, Casulla LY, et al. The changing face of Candida in Southeast Asia. In: Guerrero JJG, De Leon MP, Cena-Navarro RB, Notarte KIR, Balendres MAO, dela Cruz TEE, editors. Mycology in a Changing Planet: Applications and Perspectives from Southeast Asia. Singapore: Springer Nature Singapore. 2026:123-164. doi: 10.1007/978-981-95-2640-6_6
  9. Koleri J, Petkar HM, Al Soub HARS, AlMaslamani MARS. Candida auris blood stream infection- a descriptive study from Qatar. BMC Infect Dis. 2023;23(1):513. doi: 10.1186/s12879-023-08477-5
  10. Thangamani S, Balakumar A, Datta A, Bryak G, Lionakis MS. Host–Candida auris interactions in the skin. PLoS Pathog. 2026;22(3):e1014075. doi: 10.1371/journal.ppat.1014075
  11. Dau-Nguyen AT, Nguyen-Dang K, Tran-Le QK, et al. Emergence of Candida auris in Vietnam: a 3-year retrospective study from 2023 to 2025 at the Department of Pulmonary Medicine of Cho Ray Hospital. Medicine (Baltimore). 2026;105(1):e45932. doi: 10.1097/MD.0000000000045932
  12. Semenec L, Cain AK, Dawson CJ, et al. Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence. Nat Commun. 2023;14(1):702. doi: 10.1038/s41467-023-36252-2
  13. Mulla SA, Revdiwala S. Assessment of biofilm formation in device-associated clinical bacterial isolates in a tertiary level hospital. Indian J Pathol Microbiol. 2011;54(3):561-4. doi: 10.4103/0377-4929.85093
  14. Li Y, Ni M. Regulation of biofilm formation in Klebsiella pneumoniae. Front Microbiol. 2023;14:1238482. doi: 10.3389/fmicb.2023.1238482
  15. Hirayama T, Miyazaki T, Sumiyoshi M, et al. Echinocandin resistance in Candida auris occurs in the murine gastrointestinal tract due to FKS1 mutations. Antimicrob Agents Chemother. 2023;67(4):e01243-22. doi: 10.1128/aac.01243-22
Share
Back to top
Microbes & Immunity, Electronic ISSN: 3029-2883 Print ISSN: 3041-0886, Published by AccScience Publishing